BioLinker

Private

CotiaHealthcare & Life Scienceshttps://biolinker.tech/

Last Round

Angel

Jun 22, 2022

Total Funding Raised

$190,000

Company Overview

BioLinker is a biotechnology company that provides synthetic biology solutions, including cell-free protein expression kits and custom protein synthesis services for research and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologyrecombinant protein productioncell-free protein synthesisprotein engineeringsynbioprotein-on-demandcodon optimizationmolecular biology reagentsbiotech platformin-silico designai-driven biologybioprocess engineeringviral antigensgrowth factorsbio-foundry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioLinker Comps

Public and private peers based on sector, stage, and business model.

BioLinker comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioLinker Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Angel	Jun 22, 2022
Grant	Feb 4, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Mona Oliveira

Chief Executive Officer

Executive Team

BioLinker Investors

Notable investors and investment history

BioLinker investors
Investor	Rounds
Financiadora de Estudos e Projetos	Grant
Cietec	Accelerator
FAPESP	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 21, 2026
Grew 27% QoQ, from 11 to 14 employees.

View all signals

BioLinker Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioLinker Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioLinker's valuation, stock price, and market status.

Firmographic Details

HeadquartersCotia

Employee Range12

Year Founded2018

Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.